These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7008927)
1. [Serologic properties of antigens HLA-A, B and C]. Perreault C Can Med Assoc J; 1981 Mar; 124(6):690-7. PubMed ID: 7008927 [TBL] [Abstract][Full Text] [Related]
2. Immunodominance across HLA polymorphism: implications for cancer immunotherapy. Kim CJ; Parkinson DR; Marincola F J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431 [TBL] [Abstract][Full Text] [Related]
3. [Human major histocompatibility complex: the HLA system]. Charron D; Khalil I Rev Prat; 1994 Jan; 44(1):20-7. PubMed ID: 8178053 [TBL] [Abstract][Full Text] [Related]
4. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions. Kageshita T; Ishihara T; Campoli M; Ferrone S Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896 [TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of the HLA complex. Fischer GF; Mayr WR Wien Klin Wochenschr; 2001 Oct; 113(20-21):814-24. PubMed ID: 11732117 [TBL] [Abstract][Full Text] [Related]
6. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies. Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889 [TBL] [Abstract][Full Text] [Related]
7. The HLA system, antigen processing and presentation. Krensky AM Kidney Int Suppl; 1997 Mar; 58():S2-7. PubMed ID: 9067934 [TBL] [Abstract][Full Text] [Related]
8. [The present incidence of HLA-B and C antigens and certain cross reacting HLA-A and B antigens. Frequency of incidence in Czechoslovakia]. Májský A Vnitr Lek; 1984 Feb; 30(2):144-6. PubMed ID: 6586008 [No Abstract] [Full Text] [Related]
9. [Anti-HLA antibodies in nephropathic patients]. Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900 [TBL] [Abstract][Full Text] [Related]
10. Identification of acceptable HLA mismatches in immunized patients using single-antigen-expressing cell lines. Eijsink C; Zoet YM; Kardol MJ; Witvliet MD; Claas FH; Mulder A; Doxiadis II Tissue Antigens; 2007 Apr; 69(4):354-7. PubMed ID: 17389021 [TBL] [Abstract][Full Text] [Related]
11. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation. Barocci S; Valente U; Nocera A Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591 [TBL] [Abstract][Full Text] [Related]
12. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors. Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401 [TBL] [Abstract][Full Text] [Related]
13. Does exposure to swine leukocyte antigens after pig-to-nonhuman primate xenotransplantation provoke antibodies that cross-react with human leukocyte antigens? Key T; Schuurman HJ; Taylor CJ Xenotransplantation; 2004 Sep; 11(5):452-6. PubMed ID: 15303982 [TBL] [Abstract][Full Text] [Related]
14. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules. Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580 [TBL] [Abstract][Full Text] [Related]
15. The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes. Poláková K; Kuba D; Russ G Hum Immunol; 2004 Feb; 65(2):157-62. PubMed ID: 14969770 [TBL] [Abstract][Full Text] [Related]
16. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells. Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139 [TBL] [Abstract][Full Text] [Related]
17. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire. D'Orsogna LJ; Amir AL; Zoet YM; van der Meer-Prins PM; van der Slik AR; Kester MG; Heemskerk MH; Doxiadis II; Roelen DL; Claas FH Tissue Antigens; 2009 Oct; 74(4):290-7. PubMed ID: 19624615 [TBL] [Abstract][Full Text] [Related]
18. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies. Bućin D; Johansson S; Lindberg LO Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800 [TBL] [Abstract][Full Text] [Related]
19. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma. Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236 [TBL] [Abstract][Full Text] [Related]
20. HLA, salivary IgA and mutans streptococci--is there a relation? Wallengren ML Swed Dent J Suppl; 2004; (166):1-67. PubMed ID: 15224545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]